182 related articles for article (PubMed ID: 35454013)
1. The Need for Standardization in Next-Generation Sequencing Studies for Classic Hodgkin Lymphoma: A Systematic Review.
Santisteban-Espejo A; Bernal-Florindo I; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Romero-Garcia R; Garcia-Rojo M
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454013
[TBL] [Abstract][Full Text] [Related]
2. Whole-slide image analysis identifies a high content of Hodgkin Reed-Sternberg cells and a low content of T lymphocytes in tumor microenvironment as predictors of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD.
Santisteban-Espejo A; Bernal-Florindo I; Perez-Requena J; Atienza-Cuevas L; Maira-Gonzalez N; Garcia-Rojo M
Front Oncol; 2022; 12():1000762. PubMed ID: 36338756
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.
Mata E; Díaz-López A; Martín-Moreno AM; Sánchez-Beato M; Varela I; Mestre MJ; Santonja C; Burgos F; Menárguez J; Estévez M; Provencio M; Sánchez-Espiridión B; Díaz E; Montalbán C; Piris MA; García JF
Oncotarget; 2017 Dec; 8(67):111386-111395. PubMed ID: 29340061
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma.
Pepe F; Giordano C; Russo G; Palumbo L; Vincenzi A; Acanfora G; Lisi D; Picardi M; Pane F; Troncone G; Vigliar E
Cytopathology; 2024 Mar; 35(2):182-187. PubMed ID: 37340989
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract][Full Text] [Related]
6. The Grey Zones of Classic Hodgkin Lymphoma.
Bosch-Schips J; Granai M; Quintanilla-Martinez L; Fend F
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35159009
[TBL] [Abstract][Full Text] [Related]
7. Classic Hodgkin Lymphoma - Old Disease, New Directions: An Update on Pathology, Molecular Features and Biological Prognostic Markers.
Perry AM; Smith LB; Bagg A
Acta Med Acad; 2021 Apr; 50(1):110-125. PubMed ID: 34075767
[TBL] [Abstract][Full Text] [Related]
8. A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
van Bladel DAG; Stevens WBC; Kroeze LI; de Groen RAL; de Groot FA; van der Last-Kempkes JLM; Berendsen MR; Rijntjes J; Luijks JACW; Bonzheim I; van der Spek E; Plattel WJ; Pruijt JFM; de Jonge-Peeters SDPWM; Velders GA; Lensen C; van Bladel ER; Federmann B; Hoevenaars BM; Pastorczak A; van der Werff Ten Bosch J; Vermaat JSP; Nooijen PTGA; Hebeda KM; Fend F; Diepstra A; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
Blood Adv; 2023 Oct; 7(19):5911-5924. PubMed ID: 37552109
[TBL] [Abstract][Full Text] [Related]
9. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
[TBL] [Abstract][Full Text] [Related]
10. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
[TBL] [Abstract][Full Text] [Related]
11. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
12. The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment.
Ferrarini I; Rigo A; Visco C; Krampera M; Vinante F
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327433
[TBL] [Abstract][Full Text] [Related]
13. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Marshall A; Chavez EA; Miyata-Takata T; Ben-Neriah S; Unrau D; Telenius A; Boyle M; Weng AP; Savage KJ; Scott DW; Farinha P; Shah SP; Nelson BH; Steidl C
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615710
[TBL] [Abstract][Full Text] [Related]
14. Does rituximab have a place in treating classic hodgkin lymphoma?
Oki Y; Younes A
Curr Hematol Malig Rep; 2010 Jul; 5(3):135-9. PubMed ID: 20490723
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin lymphoma: Pathology and biology.
Mathas S; Hartmann S; Küppers R
Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
[TBL] [Abstract][Full Text] [Related]
17. Mantle Cell Lymphoma With Hodgkin and Reed-Sternberg Cells: Review With Illustrative Case.
Kramer S; Uppal G; Wang ZX; Gong JZ
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):8-14. PubMed ID: 28549034
[TBL] [Abstract][Full Text] [Related]
18. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signature in classical Hodgkin lymphoma.
Paczkowska J; Giefing M
J Appl Genet; 2021 May; 62(2):281-288. PubMed ID: 33544339
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V; Bruscaggin A; Cuccaro A; Martini M; Di Trani M; Forestieri G; Manzoni M; Condoluci A; Arribas A; Terzi-Di-Bergamo L; Locatelli SL; Cupelli E; Ceriani L; Moccia AA; Stathis A; Nassi L; Deambrogi C; Diop F; Guidetti F; Cocomazzi A; Annunziata S; Rufini V; Giordano A; Neri A; Boldorini R; Gerber B; Bertoni F; Ghielmini M; Stüssi G; Santoro A; Cavalli F; Zucca E; Larocca LM; Gaidano G; Hohaus S; Carlo-Stella C; Rossi D
Blood; 2018 May; 131(22):2413-2425. PubMed ID: 29449275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]